The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.
作者信息
Halsey N, Galazka A
出版信息
Bull World Health Organ. 1985;63(6):1151-69.
Abstract
摘要
相似文献
1
The efficacy of DPT and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age.从出生至12周龄开始的白百破疫苗和口服脊髓灰质炎疫苗免疫程序的效果。
Bull World Health Organ. 1985;63(6):1151-69.
2
[Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. I. Immune response and reactions to simultaneous administration of DPT, TOPV and hepatitis B vaccine].
Zhonghua Liu Xing Bing Xue Za Zhi. 1989 Aug;10(4):206-9.
3
4
Durability of immunity to diphtheria, tetanus and poliomyelitis after a three dose immunization schedule completed in the first eight months of life.
Vaccine. 1989 Aug;7(4):300-2. doi: 10.1016/0264-410x(89)90189-8.
5
Vaccines and immunization schedules.疫苗及免疫接种计划。
Trop Geogr Med. 1985 Sep;37(3):S42-9.
6
The antibody response of seronegative infants to inactivated poliovirus vaccine of enhanced potency.
J Biol Stand. 1986 Apr;14(2):127-31. doi: 10.1016/0092-1157(86)90031-4.
7
Antibody response of children to measles vaccine mixed with diphtheria-pertussis-tetanus or diphtheria-pertussis-tetanus-poliomyelitis vaccine.
Am J Dis Child. 1988 Mar;142(3):309-11. doi: 10.1001/archpedi.1988.02150030083026.
8
Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.白喉、破伤风、百日咳半剂量免疫：早产儿的反应
Pediatrics. 1989 Apr;83(4):471-6.
9
10
引用本文的文献
1
Precision adjuvants for pediatric vaccines.儿科疫苗的精准佐剂。
Sci Transl Med. 2024 Sep 4;16(763):eabq7378. doi: 10.1126/scitranslmed.abq7378.
2
The adjuvants dmLT and mmCT enhance humoral immune responses to a pneumococcal conjugate vaccine after both parenteral or mucosal immunization of neonatal mice.佐剂 dmLT 和 mmCT 增强了新生小鼠经皮或经粘膜免疫肺炎球菌结合疫苗后的体液免疫应答。
Front Immunol. 2023 Jan 20;13:1078904. doi: 10.3389/fimmu.2022.1078904. eCollection 2022.
3
Polio Supplementary Immunization Activities During COVID-19 Pandemic: Experience from Penampang District, Sabah, Malaysia.新冠疫情期间的脊髓灰质炎补充免疫活动：来自马来西亚沙巴州丹南地区的经验。
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211029800. doi: 10.1177/21501327211029800.
4
The CTA1-DD adjuvant strongly potentiates follicular dendritic cell function and germinal center formation, which results in improved neonatal immunization.CTA1-DD 佐剂可显著增强滤泡树突状细胞的功能和生发中心的形成，从而提高新生儿的免疫效果。
Mucosal Immunol. 2020 May;13(3):545-557. doi: 10.1038/s41385-020-0253-2. Epub 2020 Jan 20.
5
Factors That Influence the Immune Response to Vaccination.影响疫苗免疫反应的因素。
Clin Microbiol Rev. 2019 Mar 13;32(2). doi: 10.1128/CMR.00084-18. Print 2019 Mar 20.
6
Microanatomical dissection of human intestinal T-cell immunity reveals site-specific changes in gut-associated lymphoid tissues over life.人类肠道 T 细胞免疫的微观解剖揭示了肠道相关淋巴组织在一生中的特定部位变化。
Mucosal Immunol. 2019 Mar;12(2):378-389. doi: 10.1038/s41385-018-0110-8. Epub 2018 Dec 6.
7
Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.单剂无细胞百白破疫苗在出生时的免疫原性和安全性：一项随机临床试验。
JAMA Pediatr. 2018 Nov 1;172(11):1045-1052. doi: 10.1001/jamapediatrics.2018.2349.
8
Neonatal Immunization: Rationale, Current State, and Future Prospects.新生儿免疫接种：原理、现状和未来展望。
Front Immunol. 2018 Apr 4;9:532. doi: 10.3389/fimmu.2018.00532. eCollection 2018.
9
Immunogenicity of type 2 monovalent oral and inactivated poliovirus vaccines for type 2 poliovirus outbreak response: an open-label, randomised controlled trial.2 型单价口服减毒活疫苗和 2 型脊灰病毒疫苗用于 2 型脊灰病毒暴发应对的免疫原性：一项开放标签、随机对照试验。
Lancet Infect Dis. 2018 Jun;18(6):657-665. doi: 10.1016/S1473-3099(18)30113-0. Epub 2018 Mar 20.
10
Causes of impaired oral vaccine efficacy in developing countries.发展中国家口腔疫苗效力受损的原因。
Future Microbiol. 2018 Jan;13(1):97-118. doi: 10.2217/fmb-2017-0128. Epub 2017 Dec 8.
本文引用的文献
1
Response of infants to diphtheria immunization.
Lancet. 1949 Jan 1;1(6540):16-8. doi: 10.1016/s0140-6736(49)90343-8.
2
Concentration of diphtheria antitoxin in cord blood and rate of loss in babies.脐血中白喉抗毒素的浓度及婴儿体内的丢失率。
Lancet. 1949 Aug 20;2(6573):324-6. doi: 10.1016/s0140-6736(49)90047-1.
3
4
Combined immunization against diphtheria, tetanus and pertussis in newborn infants, duration of antibody levels; antibody titers after booster dose; effect of passive immunity to diphtheria on active immunization with diphtheria toxoid.新生儿白喉、破伤风和百日咳联合免疫：抗体水平持续时间；加强剂量后的抗体滴度；白喉被动免疫对用白喉类毒素进行主动免疫的影响。
Pediatrics. 1949 Feb;3(2):181-94.
5
6
Simultaneous immunization of young children against diphtheria, tetanus, and pertussis; experience in a northern metropolitan area.幼儿同时接种白喉、破伤风和百日咳疫苗；在一个北部大都市地区的经验。
Am J Public Health Nations Health. 1950 Jun;40(6):681-5. doi: 10.2105/ajph.40.6.681.
7
8
Immunization in the young infant; response to combined vaccines. VI-X.
AMA Am J Dis Child. 1951 Apr;81(4):518-29. doi: 10.1001/archpedi.1951.02040030529005.
9
Immunization in the young infant; response to combined vaccines. V.婴儿期免疫；对联合疫苗的反应。五。
AMA Am J Dis Child. 1951 Apr;81(4):501-17.
10
Immunization in the young infant; response to combined vaccines. I-IV.
AMA Am J Dis Child. 1951 Apr;81(4):483-500.
Zotero 插件